Trump Bought Stock in Drugmaker Whom It Then Boosted Through Policy
Source: Truthout · Bias: Far Left
Summary
The president made trades in Eli Lilly early this year while making decisions benefiting the drugmaker’s GLP-1 business.
Related Coverage
- Melania gives Congress private deadline as she works around Trump's team: report (Far Left — Raw Story)
- Trump announces pardons for pollution violators prosecuted for "fixing their car" (Center — Politics - CBSNews.com)
- Trump Pardons Six People Pursued for ‘Fixing Their Car’ (Center — Bloomberg Politics)
- Sources: Trump likely to pardon pollution violators; weighing clemency for Diddy (Center — Politics - CBSNews.com)
- Fox host warns Trump will pay for his 'breathtaking' corruption (Left — Alternet.org)
- Trump Scores Appeals Court Victory in Battle Over National Park Historical Displays (Right — RedState)
- Signs of Victory: I-95 Welcomes President Donald Trump Int'l Airport (Right — RedState)
- Trump’s ‘ramped up’ rhetoric leaves unifying tone of July Fourth speech in question (Center Left — NBC News Politics)
Daily Analysis
Read the full Parallax Pulse for May 18, 2026 — an AI-powered analysis of how Left and Right media covered the biggest stories this day.
More Headlines From May 18, 2026
- Trump settles IRS lawsuit, sets up $1.7B fund for claims of "weaponization" (Center)
- US Approves $4.2 Billion in Helicopters, Upgrades for Seoul (Center)
- Trump’s pledge to 'drain the swamp' is a 'cosmic joke': Reagan insider (Left)
- US bans foreign travelers from Ebola-impacted nations (Center)
- These Republicans are bucking Trump by throwing support behind Thomas Massie (Far Right)





